Description
Mazdutide is a dual GLP-1/glucagon receptor agonist developed in China and studied primarily in East Asian trial cohorts, giving it a distinct pharmacological and population profile compared with Western incretin analogues. Its glucagon component is of particular interest to researchers studying energy-expenditure pathways separately from appetite suppression.
Laboratories working on comparative incretin pharmacology often request mazdutide alongside tirzepatide or retatrutide to map how different receptor combinations affect lipid metabolism and hepatic fat markers in preclinical models.
After you place your order, a licensed physician will speak with you directly on a live call to review your health history and confirm a prescription is medically appropriate before anything ships. If your order isn’t approved, our team will contact you directly instead of shipping it. Reconstitute with bacteriostatic water immediately prior to use and store refrigerated, shielded from light.
